Digestive Disease Articles & Analysis
25 news found
The data was presented at the annual Digestive Disease Week (DDW) conference in May. Results from a Multicenter Randomized Sham-controlled Trial of a Duodenal Jejunal Bypass Liner for the Treatment of Type 2 Diabetes Mellitus were presented by Christopher C. ...
MOUNTAIN VIEW, Calif., May 26, 2022 – G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced that two posters were presented at Digestive Disease Week Conference held in San Diego in from May 21 through May 24. ...
About VE202 VE202 is a first-in-class defined bacterial consortium therapeutic candidate for the treatment of inflammatory bowel disease (IBD). It consists of 16 bacterial strains of the Clostridia class that were rationally selected. ...
These data were shared in oral and poster presentations at the 2022 Digestive Disease Week (DDW) Annual Meeting. “These results suggest that our investigational microbiome therapeutic, SER-109, is a potentially fast-acting intervention that can provide durable relief from recurrent C. difficile infections when administered to vulnerable patients,” ...
On the basis of clinical success and acknowledged leadership in the field of celiac disease, the organizers of the International Celiac Disease Symposium (ICDS) have invited Jack Syage PhD, CEO of ImmunogenX, to deliver a panel talk and join the Conference Faculty. ...
(Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that it will present data from its ECOSPOR III trial of SER-109 at the Digestive Disease Week® (DDW) Annual Meeting, which is taking place May 21-24, 2022. ...
This $1.6 million award from the National Institute of Diabetes and Digestive Kidney Disease (NIDDK) will allow the company to pursue additional research in the use of AVM0703 as a monotherapy and combination therapy to reverse recent onset and established Type 1 Diabetes (T1D). T1D is an autoimmune disease that destroys beta cells, the ...
CoapTech LLC announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the National Institutes of Health (NIH) awarded the company a two-year, $1.2M R44 Small Business Innovation Research (SBIR) Phase II grant on August 29, 2019. ...
ByCoapTech
MOUNTAIN VIEW, Calif., March 15, 2022 – G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced that two posters have been accepted for presentation at the upcoming Digestive Disease Week Conference to be held in San Diego in from May 21 through May 24. ...
Based on the results obtained from the CeliacShieldTM trial (NCT03585478) by ImmunogenX, Inc. and conducted at the Mayo Clinic, the work has been selected as a Lecture Presentation at the 2022 Digestive Disease Week® (DDW) Conference, the foremost gastroenterological event in the world, being held at the San Diego Convention Center, San Diego, CA on May ...
Located in downtown Orlando, the Orlando Health Digestive Health Institute is a national and international destination for care. The Institute is a state-of-the-art digestive diseases facility that features technologically advanced procedure rooms, preoperative and recovery bays, and support space for patients and staff. ...
Chan, head of the Division of Gastroenterology and Hepatology, Director of the Institute of Digestive Disease, the Center for Liver Health, and the Office of Global Engagement. ...
(the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into colorectal cancer (CRC), today announced the publication of research titled "Colorectal cancer and polyp detection using a new ...
Leveraging an extensive library of both public and proprietary molecular data, CytoReason's technology allows scientists to gain critical information on the body's functioning, and to address diseases such as IBD at the cellular level. IBD is a lifelong, chronic disease that affects the digestive system, and includes Crohn's ...
CoapTech Inc. announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the National Institutes of Health (NIH) awarded CoapTech a two-year, $1.6M R44 Small Business Innovation Research (SBIR) Phase II grant on September 22, 2020 to finalize development of and trial its Pediatric PUMA-G System. ...
ByCoapTech
Addressing an Unmet Medical Need There is a great need for treatments targeting fibrosis related to Chronic Kidney Disease (CKD). Kidney fibrosis (KF) is a pathological hallmark of CKD and a major contributing factor to progression to end-stage CKD. ...
Kantsevoy, MD, PhD, FJGES, Director of the Therapeutic Endoscopy at Melissa L. Posner Institute for Digestive Health and Liver Disease at Mercy Medical Center, Baltimore, Maryland, performed the procedure. ...
The product will be made available for discussion during the upcoming Digestive Disease Week held in Washington DC, June 2-5, 2018. EndoClot® Adhesive is a single-use kit that consists of Adhesive Hemostatic Polymer (AHP) and a unique applicator system to ensure accurate delivery of the hemostatic powder to the lesion within the GI tract. ...
Healionics Corporation, a Seattle-based medical device company, has received notice from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of a $1.7M Fast-Track Small Business Innovation Research (SBIR) grant in support of regulatory approval and a clinical study of STARgraftTM, its innovative synthetic vascular graft. ...
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today the availability of several new endoscopic therapeutic devices, to be unveiled at the upcoming Digestive Disease Week conference May 6-9 in Chicago, Ill. The expansion of the market leading ...